Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spleen Stiffness as a Measure to Assess the REsponse to β Blocker Therapy (SPARE-B).

NCT06050837 is registered in ClinicalTrials.gov with Institute of Liver and Biliary Sciences, India as lead sponsor.

NCT NCT06050837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06050837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spleen Stiffness as a Measure to Assess the REsponse to β Blocker Therapy (SPARE-B).
Lead sponsor
Institute of Liver and Biliary Sciences, India
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2023
Completion date
August 31, 2024
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high risk esophageal varices